<DOC>
	<DOCNO>NCT01916902</DOCNO>
	<brief_summary>Subjects present probable acute coronary syndrome schedule cardiac catheterization enrol study . Consented subject randomize receive ticagrelor start load dose immediately enrollment versus receive load dose ticagrelor cardiac catheterization diagnostic angiography prior stenting . Optical coherence tomography ( OCT ) perform stenting volume thrombus within new stent measure compare group .</brief_summary>
	<brief_title>Effect Pretreatment With Ticagrelor Residual Thrombus After PCI Patients Presenting With ACS Comparison With Delayed Treatment Time PCI : OCT Study</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Acute Coronary Syndrome</mesh_term>
	<mesh_term>Ticagrelor</mesh_term>
	<criteria>Patient Characteristics : 1 . Males nonpregnant female &gt; equal 18 &lt; equal 79 year age presenting suspect acute coronary syndrome ( unstable angina NSTEMI ) 2 . Patients likely scheduled undergo coronary angiography possible percutaneous coronary intervention ( PCI ) Lesion Characteristics Diagnostic Coronary Angiography : 1 . De novo lesion native coronary artery find diagnostic coronary angiography 2 . Angiographic stenosis &lt; 100 % 3 . Reference vessel diameter 2.5 mm 4.0 mm visual estimation Patient Specific 1 . Subjects unable unwilling sign inform consent form . 2 . Subjects treat antiplatelet medication aspirin prior diagnostic catheterization include glycoprotein IIb/IIIa inhibitor . 3 . Subjects serious comorbid condition judgment investigator preclude inclusion study 4 . Subjects NYHA class III IV heart failure know leave ventricular ejection fraction &lt; 30 % . 5 . Subjects ST elevation myocardial infarction . 6 . Subjects hemodynamic electrical instability ( include shock ) . 7 . Subjects diagnose severe , noncatheterrelated coronary artery spasm . 8 . Subjects may pregnant . 9 . Subjects know allergy contrast medium . 10 . Subjects eGFR &lt; 60 ml/min/1.73m2 . 11 . Subjects currently take oral anticoagulant absolute contraindication discontinuation anticoagulation . 12 . History TIA stroke &lt; 6 month . 13 . History hemorrhagic stroke . 14 . Hepatic insufficiency define liver cirrhosis , AST/ALT/Alkaline Phosphatase great 3 time upper limit normal hyperbilirubinemia . 15 . Cardiac catheterization schedule within 4 hour randomization 72 hour randomization . Lesion Specific Exclusion Criteria . These exclusion criterion apply target lesion image OCT. 1 . Lesions locate leave main coronary artery 2 . Lesions heavily calcify 3 . Lesions OCT perform due technical difficulty 4 . Other lesion investigator deems inappropriate procedure sit excessive tortuosity low flow TIMI grade . 5 . Lesions saphenous vein graft arterial conduit .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>79 Years</maximum_age>
	<verification_date>May 2014</verification_date>
	<keyword>Optical Coherence Tomography</keyword>
	<keyword>Ticagrelor</keyword>
</DOC>